Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60M
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
1.69M
-
Shares change
-
+822K
-
Total reported value, excl. options
-
$17.4M
-
Value change
-
+$8.39M
-
Number of buys
-
12
-
Price
-
$10.18
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q1 2015
15 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2015.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.69M shares
of 60M outstanding shares and own 2.82% of the company stock.
Largest 10 shareholders include FMR LLC (835K shares), PERCEPTIVE ADVISORS LLC (357K shares), BAKER BROS. ADVISORS LP (142K shares), Knoll Capital Management, LP (136K shares), SPHERA FUNDS MANAGEMENT LTD. (115K shares), DAFNA Capital Management LLC (35K shares), Spark Investment Management LLC (22.7K shares), GEODE CAPITAL MANAGEMENT, LLC (22.6K shares), MORGAN STANLEY (13.8K shares), and Nicholas Investment Partners, LP (8.33K shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.